Aug 29 (Reuters) - Kalytera Therapeutics Inc KLY.V :
* KALYTERA REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.01
* IN Q2 2019, COMPANY HAD NO REVENUES FROM PRODUCT SALES
* CURRENTLY IN PROCESS OF CLOSING A MANAGEMENT-LED PRIVATE PLACEMENT OF UP TO APPROXIMATELY $1.1 MILLION